ABX464-话题@MedSci

#ABX464#

3篇内容 | 475人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2036558, encodeId=c77a203655866, content=<a href='/topic/show?id=0e771e922b' target=_blank style='color:#2F92EE;'>#ABX464#</a>, objectTitle=美国FDA批准ABX464进行临床试验以治疗中重度溃疡性结肠炎, objectType=article, longId=186611, objectId=019918661107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=019918661107, replyNumber=0, likeNumber=29, createdTime=2020-06-28, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=019918661107, moduleTitle=美国FDA批准ABX464进行临床试验以治疗中重度溃疡性结肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=019918661107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036556, encodeId=2ffc2036556bf, content=<a href='/topic/show?id=0e771e922b' target=_blank style='color:#2F92EE;'>#ABX464#</a>, objectTitle=Sci Rep：ABX464独特的作用机制，同时产生抗炎和抗病毒作用, objectType=article, longId=159165, objectId=27791591650a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27791591650a, replyNumber=0, likeNumber=31, createdTime=2019-10-08, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27791591650a, moduleTitle=Sci Rep：ABX464独特的作用机制，同时产生抗炎和抗病毒作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27791591650a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036557, encodeId=00d7203655efe, content=<a href='/topic/show?id=0e771e922b' target=_blank style='color:#2F92EE;'>#ABX464#</a>, objectTitle=Abivax将在两个会议上介绍其先导化合物ABX464的全新临床数据, objectType=article, longId=161014, objectId=2b10161014fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b10161014fa, replyNumber=0, likeNumber=33, createdTime=2020-02-09, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b10161014fa, moduleTitle=Abivax将在两个会议上介绍其先导化合物ABX464的全新临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b10161014fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ABX464

2020-05-29

juliusluan78 (审核中...)

前往app查看评论内容

#ABX464#

美国FDA批准ABX464进行临床试验以治疗中重度溃疡性结肠炎

2020-06-28

juliusluan78 (审核中...)

前往app查看评论内容

#ABX464#

Sci Rep：ABX464独特的作用机制，同时产生抗炎和抗病毒作用

2019-10-08

juliusluan78 (审核中...)

前往app查看评论内容

#ABX464#

Abivax将在两个会议上介绍其先导化合物ABX464的全新临床数据

2020-02-09

科室
- - 订阅+
  - 更多科室
工具
服务